Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 1259-1261, 2004; 10.1373/clinchem.2004.032649
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsikas, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsikas, D.
Related Collections
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2004;50:1259-1261.)
© 2004 American Association for Clinical Chemistry, Inc.

Technical Briefs

Mass Spectrometry-Validated HPLC Method for Urinary Nitrate

Dimitrios Tsikas

1 Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany

afax 49-511-5322750, e-mail tsikas.dimitros@mh-hannover.de

The first 300 words of the full text of this article appear below.

The L-arginine/NO biosynthetic pathway is involved in many physiologic and pathologic processes, including vasodilation and inhibition of platelet aggregation and adhesion. Nitrate (NO3–) and nitrite (NO2–) are the most abundant circulating and excretory NO metabolites in humans. In humans on a standardized low nitrate/nitrite diet, circulating nitrite reflects constitutive NO synthase activity (1), whereas measurement of nitrate in urine is a reliable noninvasive method to assess whole-body NO synthesis in humans (2).

Current analytical methods for the measurement of nitrate and nitrite include spectrophotometry, chemiluminescence, capillary electrophoresis, assays based on the Griess reaction, HPLC, and gas chromatography-mass spectrometry (GC-MS) (3). Among these assays, GC-MS methods form the basis for reference methods (4). Numerous HPLC methods using ultraviolet, electrochemical, or fluorescence detection have been reported for the analysis of nitrate and nitrite (3). The majority of them, however, have not been validated against MS, and they are mostly limited to human plasma (5) or rat urine (6). Recently, a commercially available HPLC-Griess system has been used for the analysis of urinary nitrite/nitrate in humans (7), but it has not been externally validated, and analysis of nitrate requires its reduction to nitrite.

Here I report on a simple, rapid, GC-MS-validated anion-pairing HPLC method with ultraviolet absorbance detection at 205 nm for the accurate measurement of nitrate in human urine without sample pretreatment other than dilution of samples with the mobile phase. This HPLC method is not suitable to measure nitrate in human plasma.

HPLC analyses were performed with a Pharmacia LKB pump Model 2248 and an analytical column [250 x 4 mm (i.d.)] packed with Nucleosil 100–5C18 AB (Macherey-Nagel). The mobile phase consisted of water-acetonitrile (90:10 by volume) contained 10 mmol/L tetrabutylammoniumhydrogen sulfate . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.